Gastrointestinal micro and mycobiome profile in chemotherapy and stem cell transplantation for hematological malignancies

Gastrointestinal micro and mycobiome profile in chemotherapy and stem cell transplantation for hematological malignancies - Chiba micro-mycobiome study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027086

Enrollment

200

Registered

2017-04-21

Start date

2017-04-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hematological malignancies (acute leukemia and malignant lymphoma)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) 16 years old or older 2) Patients with Newly or previously diagnosed hematological malignancy who will initiate combination chemotherapy in hospitalized setting 3) More than 1 month chemotherapeutic interval is required in previously diagnosed patients

Exclusion criteria

Exclusion criteria: 1) Patients who previously received chemotherapeutic agents within 1 month 2) Patients considered to be ineligible by physicians

Design outcomes

Primary

Measure	Time frame
Changes in gastrointestinal microbial diversity during combination chemaotherapy	—

Countries

Japan

Contacts

Public ContactChikako Ohwada

Chiba University Hospital Department of Hematology

chikako_ohwada@faculty.chiba-u.jp043-222-7171

Outcome results